The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.

Bugonia tells the story of a conspiracy theorist abducting a CEO, believing her to be an alien. However, things turn out wilder than his expectations.

Gov. Glenn Youngkin announced a landmark partnership Friday with AstraZeneca, Lilly and Merck to create the nation’s largest ...

The abrupt departure of Lyell Immunopharma's chief financial officer has created uncertainty about the biotechnology firm's ...

AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

WebMD calls the bad-breath herb a “low-cal immunity-boosting superstar” and “elixir.” In addition to being delicious, garlic ...

The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...